WTAP through m6A methylation modification leads to the post-transcriptional inhibition of HuR-ETS1, inhibits the E21-mediated P21/P27-dependent regulation of G2/M phase progression of hepatoma cell cycle, and promotes the proliferation and tumor growth of hepatoma cells (88). Here, ELAVL1 is linked to hepatocellular carcinoma.